Global Custom Market Research Reports Provider Company

phone

Poxel SA (POXEL) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: France
Summary

Poxel SA (Poxel) is a biopharmaceutical company that develops and markets drugs for metabolic diseases. The companys products comprise imeglimin, AMPK, GLP-1, FXR, 11B-HSD1 and GKA. Its imeglimin targets mitochondrial dysfunction. Poxel also offers in-licensing of its products. The companys PXL770 directly activates adenosine monophosphate-activated protein kinase that controls whole-body energy metabolism and plays an important role in the management of diabetes. It collaborates with various universities and research centers to develop new drugs. The company markets its products in France and abroad. Poxel is headquartered in Lyon, France.

Poxel SA Key Recent Developments

Oct 16,2017: Poxel Announces Third Quarter 2017 Financial Update
Sep 21,2017: Poxel Reports Results for the First Half 2017 and Provides Corporate Update
Jul 11,2017: Poxel Appoints Kumi Sato to its Board of Directors
Jul 10,2017: Poxel Announces Second Quarter 2017 Financial Update
May 04,2017: Poxel Announces First Quarter 2017 Financial Update

This comprehensive SWOT profile of Poxel SA provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Poxel SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Poxel SA - Key Information

Poxel SA - Overview

Poxel SA - Key Employees

Poxel SA - Key Employee Biographies

Poxel SA - Key Operational Heads

Poxel SA - Major Products and Services

Poxel SA - History

Poxel SA - Company Statement

Poxel SA - Locations And Subsidiaries

Poxel SA - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Poxel SA - Business Description

Poxel SA - Corporate Strategy

Poxel SA - SWOT Analysis

SWOT Analysis - Overview

Poxel SA - Strengths

Poxel SA - Weaknesses

Poxel SA - Opportunities

Poxel SA - Threats

Poxel SA - Key Competitors



Section 3 - Company Financial Performance Charts



Poxel SA - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Poxel SA, Key Information

Poxel SA, Key Ratios

Poxel SA, Share Data

Poxel SA, Major Products and Services

Poxel SA, History

Poxel SA, Key Employees

Poxel SA, Key Employee Biographies

Poxel SA, Key Operational Heads

Poxel SA, Other Locations

Poxel SA, Subsidiaries

Poxel SA, Key Manufacturing facilities

Poxel SA, Key Competitors

Poxel SA, SWOT Analysis

Poxel SA, Ratios based on current share price

Poxel SA, Annual Ratios

Poxel SA, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Poxel SA, Performance Chart

Poxel SA, Ratio Charts

Poxel SA (Poxel) is a biopharmaceutical company that develops and markets drugs for metabolic diseases. The companys products comprise imeglimin, AMPK, GLP-1, FXR, 11B-HSD1 and GKA. Its imeglimin targets mitochondrial

View Report

Poxel SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile market research report at USD 250 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports